Glucose Metabolism Disorders: all 361 studies
Page 1 of 4. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.
- Reproducibility of Continuous Glucose Monitoring (CGM) in the Assessment of Glucose Metabolism Disorders in Children With Cystic FibrosisNot yet recruitingNCT07851831Not applicable
- Glycemic Control and Quality of Life Evolution for Patients With T1D Using the myLoop Powered by CamAPS FX System in Combination With FreeStyle Libre 3 / 3 Plus Sensors in FranceNot yet recruitingNCT07835685
- Bao Yuan Tang Extract and Galactooligosaccharides for Sleep RegulationNot yet recruitingNCT07774897Not applicable
- A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy ParticipantsRecruitingNCT07723833Phase 1
- METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)RecruitingNCT07699380Phase 2
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingRecruitingNCT07613307Phase 3
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityRecruitingNCT07595549Phase 3
- Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal DiseaseNot yet recruitingNCT07580079Phase 2
- Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West IndiesNot yet recruitingNCT07576374
- The CGM-OGTT Glycemic Homeostasis StudyNot yet recruitingNCT07288372
- The Effect of Chlorhexidine Mouthwash on Postprandial Glucose Response in Healthy IndividualsRecruitingNCT07172009Not applicable
- Metabolic Effects of Endogenous Bile Acids After Gastric Bypass SurgeryRecruitingNCT06925997Early Phase 1
- Postprandial Metabolome and Metabolic FlexibilityRecruitingNCT06878781Not applicable
- Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary BypassRecruitingNCT06861881Not applicable
- Impact of Chromium Supplementation on Glucido-lipidic Metabolism, Oxidative Stress and Inflammatory State in Patients with Gestational DiabetesNot yet recruitingNCT06860087Phase 1/2
- Acute Metabolic Effects of Tirzepatide in Type 1 DiabetesRecruitingNCT06820281Phase 2
- Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot UlcersRecruitingNCT06681428Not applicable
- Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUsRecruitingNCT06674980Not applicable
- Study of Time-restricted Eating (TRE) to Clinical Pregnancy Rate in PCOS Women With Glucose Metabolism Disorder Via IVF/ICSIEnrolling by invitationNCT06666933Not applicable
- Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring ProgramRecruitingNCT06636383
- A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusRecruitingNCT06575426Phase 1/2
- In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 DiabetesRecruitingNCT06557317Not applicable
- Multidisciplinary Care for Lifestyle Change for Metabolic Control and Quality of Life in Prediabetes (PreCPro)RecruitingNCT06468553Not applicable
- Henagliflozin's Impact on Prediabetes RemissionNot yet recruitingNCT06448130Phase 4
- Glycaemic Index Determination in Oral Nutrition SupplementsRecruitingNCT06358716Not applicable
- Continuous Glucose Monitoring Glycemic cHAracterization During PregnancyRecruitingNCT06357728Not applicable
- The Role of Oxytocin in Regulating Blood GlucoseRecruitingNCT06334172Not applicable
- Relationship Between Individual Effect of Diet on Postprandial Glycemia and Gut Microbiome Profile in Healthy SubjectsRecruitingNCT06051318Not applicable
- Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusRecruitingNCT05779644Not applicable
- The Relationship Between Diet and Glycemic Response and Inflammatory Markers in Children With Cystic FibrosisRecruitingNCT05748444
- Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in ChinaRecruitingNCT05726461Not applicable
- Rare and Atypical Diabetes NetworkRecruitingNCT05544266
- Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 DiabetesRecruitingNCT05543083Not applicable
- Utility of 18FDOPA PET/MRI for Focal HyperinsulinismRecruitingNCT05088798Phase 2
- Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic DiseaseRecruitingNCT05085704
- Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 DiabetesRecruitingNCT04874012Phase 2
- Animal and Plant Proteins and Glucose MetabolismRecruitingNCT03994367Not applicable
- Regulation of Endogenous Glucose Production by Central KATP ChannelsRecruitingNCT03540758Phase 2
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 DiabetesCompletedNCT05691712Phase 3Results posted
- Nu-3 Topical Gel for Treatment of Diabetic Foot UlcerTerminatedNCT05276401Phase 2Results posted
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or BothCompletedNCT05260021Phase 3Results posted
- A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)CompletedNCT05139316Phase 3Results posted
- Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II DiabetesCompletedNCT05014204Not applicableResults posted
- A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesCompletedNCT04809220Phase 3Results posted
- Effect of NMN Supplementation on Organ System BiologyCompletedNCT04571008Not applicableResults posted
- An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital HyperinsulinismCompletedNCT04538989Phase 2Results posted
- Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management PlatformCompletedNCT04369833Results posted
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesCompletedNCT04255433Phase 3Results posted
- Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart FailureTerminatedNCT04071626Phase 4Results posted
- Glucose and Non-Invasive Brain StimulationTerminatedNCT04031404Not applicableResults posted
- Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type IaCompletedNCT03970278Results posted
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskCompletedNCT03730662Phase 3Results posted
- Low-Carbohydrate Dietary Pattern on Glycemic Outcomes TrialCompletedNCT03675360Not applicableResults posted
- Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 DiabetesCompletedNCT03653091Not applicableResults posted
- Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to DiazoxideTerminatedNCT03566511Phase 2Results posted
- Safety and Dose-Finding Study of DTX401 (AAV8G6PC) in Adults With Glycogen Storage Disease Type Ia (GSDIa)CompletedNCT03517085Phase 1/2Results posted
- Soluble Epoxide Hydrolase Inhibition and Insulin ResistanceCompletedNCT03486223Phase 2Results posted
- Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver DiseaseCompletedNCT03371355Phase 2Results posted
- Spectrophon LTD Glucometry Monitor AccuracyCompletedNCT03359629Results posted
- Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 DiabetesCompletedNCT03345004Phase 2Results posted
- Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 DiabetesCompletedNCT03199638Not applicableResults posted
- Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)CompletedNCT03181399Phase 2Results posted
- Day and Night Closed-loop in Young People With Type 1 DiabetesCompletedNCT02925299Not applicableResults posted
- Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric HypoglycemiaCompletedNCT02771574Phase 2Results posted
- Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery PatientsCompletedNCT02733588Phase 2Results posted
- EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 DiabetesCompletedNCT02464033Phase 2Results posted
- GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)CompletedNCT02352974Phase 1Results posted
- A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)CompletedNCT02004886Phase 2Results posted
- Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)CompletedNCT01841697Phase 3Results posted
- A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)CompletedNCT01814748Phase 3Results posted
- A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)CompletedNCT01767688Phase 1Results posted
- Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)TerminatedNCT01601704Phase 3Results posted
- Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH StudyCompletedNCT01435603Not applicableResults posted
- Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in HumansCompletedNCT01354977Phase 2Results posted
- Effect of Vitamin D Repletion on Insulin Resistance and Systemic InflammationCompletedNCT01354964Phase 2Results posted
- Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult FemalesCompletedNCT01301456Phase 1Results posted
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive MedicationCompletedNCT01195662Phase 3Results posted
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerCompletedNCT01137474Phase 3Results posted
- Aldosterone and the Metabolic SyndromeCompletedNCT01103245Phase 1Results posted
- Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily InjectionsCompletedNCT01073566Phase 2Results posted
- Central Mechanisms That Regulate Glucose Metabolism in HumansTerminatedNCT01028846Phase 4Results posted
- A Study of LY2189265 in Japanese Patients With Type 2 DiabetesCompletedNCT01001104Phase 2Results posted
- Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeCompletedNCT00968708Phase 3Results posted
- Effect of Fish Oil (Omega-3 Fatty Acids) on ArteriesTerminatedNCT00935766Phase 3Results posted
- Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesCompletedNCT00859898Phase 3Results posted
- Effect of Exendin (9-39) on Glucose Requirements to Maintain EuglycemiaTerminatedNCT00835328Phase 1/2Results posted
- Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and OverweightCompletedNCT00834652Phase 4Results posted
- Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.CompletedNCT00770653Phase 3Results posted
- Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic AdultsTerminatedNCT00737633Phase 2Results posted
- Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 DiabetesCompletedNCT00736879Phase 3Results posted
- Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.CompletedNCT00727857Phase 3Results posted
- Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.CompletedNCT00708175Phase 4Results posted
- Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsCompletedNCT00707993Phase 3Results posted
- Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.CompletedNCT00655863Phase 3Results posted
- A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic AdultsCompletedNCT00600067Phase 2Results posted
- A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneCompletedNCT00528879Phase 3Results posted
- Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00432276Phase 3Results posted
- Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusCompletedNCT00395512Phase 3Results posted
- Long-term Safety of Alogliptin in Patients With Type 2 Diabetes MellitusCompletedNCT00306384Phase 3Results posted
- Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00286494Phase 3Results posted